Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Neoplasms

Explore clinical trials studying Pancreatic Neoplasms. Study availability and eligibility vary by location and protocol.

2,458 public trials 581 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Neoplasms trial results

Active, Not Recruiting

Nordic Pancreatic Cancer Trial (NorPACT) - 1

NCT02919787

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Odense University Hospital Odense, Denmark
  • Helsinki University Hospital Helsinki, Finland
  • Oslo University Hospital Oslo, Norway
  • Haukeland University Hospital Bergen, Norway
View all 13 locations
View Trial Details
Active, Not Recruiting

An Open-label, Uncontrolled Study of ONO-7913 and ONO-4538 in Combination With Modified FOLFIRINOX Therapy, the Standard of Care, as First-line Treatment in Patients With Metastatic Pancreatic Cancer

NCT06532344

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • National Cancer Center Hospital East Kashiwa-shi, Chiba, Japan
  • Kanagawa Cancer Center Yokohama, Kanagawa, Japan
  • Seirei Hamamatsu General Hospital Hamamatsu, Shizuoka, Japan
  • Juntendo University Hospital Bunkyō-Ku, Tokyo, Japan
View Trial Details
Active, Not Recruiting

First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer

NCT05159440

Conditions
Advanced Solid Tumor, Digestive System Diseases, Digestive System Neoplasms, +13 more
Locations
  • Providence St. Jude Medical Center Fullerton, California, United States
  • UCLA - JCCC Clinical Research Unit Los Angeles, California, United States
  • Torrance Memorial Medical Torrance, California, United States
  • Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
View Trial Details
Active, Not Recruiting

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

NCT05215574

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +83 more
Locations
  • NGM Clinical Study Site Gilbert, Arizona, United States
  • NGM Clinical Study Site Los Angeles, California, United States
  • NGM Clinical Study Site Sarasota, Florida, United States
  • NGM Clinical Study Site Tampa, Florida, United States
View Trial Details
Active, Not Recruiting

Tg01 Vaccine / Qs-21 Stimulon™ With Or Without Balstilimab As Maintenance Therapy Following Adjuvant Chemotherapy In Patients With Resected Pancreatic Cancer

NCT05638698

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • University of Kansas Cancer Center - Clinical Research Center Fairway, Kansas, United States
  • University of Kansas Cancer Center - Overland Park Overland Park, Kansas, United States
  • University of Kansas Cancer Center - Westwood Westwood, Kansas, United States
  • University of Kansas Cancer Center - North Kansas City, Missouri, United States
View Trial Details
Active, Not Recruiting

ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors

NCT04205227

Conditions
Adnexal Diseases, Cancer, Digestive System Diseases, +30 more
Locations
  • Cedars Sinai-The Angeles Clinic Los Angeles, California, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Border Medical Oncology Albury, New South Wales, Australia
  • Blacktown Oncology Blacktown, New South Wales, Australia
View Trial Details

Related conditions